http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S59155318-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9025552a2fe81402099337b7fce9f87 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate | 1983-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6222ba2c82b2c369a3e0b1d82a985a33 |
| publicationDate | 1984-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-S59155318-A |
| titleOfInvention | Cell activator and its utilization |
| abstract | PURPOSE: A cell activator that contains dl-camphor or 1-menthol. n CONSTITUTION: An orally applicable cell activator is obtained by using 9.6% of dl-camphor, 1.35% of 1-menthol, 1.30% of eucalyptus oil, 66.44% of white petrolatum, 0.36% of pine oil and 0.22% of methyl salicylate. Further, another external use cell activator is obtained by using 2.6g of dl-camphor, 12.0g of 1-menthol, 2.0g of safrol, 1.68g of thymol, 0.24g of vitamin E acetate ester, 13.2g(per 1m 2 area) of methyl salicylate. Restriction enzymes can be used as an auxiliary agent of the activator. The orally applicable activator is also used by coating it in the cavity of nose and mouth to activate the cells in lungs and interbrain. Further, the preparation for external use can be applied to near the heart to prevent heart failure or paralysis. n COPYRIGHT: (C)1984,JPO&Japio |
| priorityDate | 1983-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.